# OPKO Health (OPK) — News

OPK · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/opk/news

## Recent headlines

- [OPKO Health shares up 14% to $1.56 on sale of select assets to LabCorp for up to $872 mln](https://www.ainvest.com/news/opko-health-shares-14-1-56-sale-select-assets-labcorp-872-mln-2610) — AInvest Wire, Oct 15, 2026
  OPKO Health, Inc. (Nasdaq: OPK) shares rose 14% to $1.56 on Monday following the announcement that the company has agreed to sell select assets of its subsidiary, BioReference Health, to Labcorp (NYSE: LH) for up to $872 million. The transaction includes BioReference Health’s laboratory testing…
- [OPKO Health shares up 29.2% to $1.77 premarket after LabCorp to buy select assets from co's unit for up to $872 mln](https://www.ainvest.com/news/opko-health-shares-29-2-1-77-premarket-labcorp-buy-select-assets-unit-872-mln-2610) — AInvest Wire, Oct 15, 2026
- [OPKO Health shares extend premarket climb to 34%](https://www.ainvest.com/news/opko-health-shares-extend-premarket-climb-34-2610) — AInvest Wire, Oct 15, 2026
  OPKO Health, Inc. (OPK) shares rose sharply in premarket trading on October 15, 2026, climbing 34% following a strong performance in the previous session. The stock has shown mixed returns over the long term, with a 5-year total return of 63.56% compared to the S&P 500’s 73.92%. However, the…
- [OPKO Health shares gain 10% as LabCorp to buy select assets](https://www.ainvest.com/news/opko-health-shares-gain-10-labcorp-buy-select-assets-2610) — AInvest Wire, Oct 15, 2026
- [OPKO Health - Deal valued at $722 mln cash plus up to $150 mln earnout based on 4Kscore test revenue](https://www.ainvest.com/news/opko-health-deal-valued-722-mln-cash-150-mln-earnout-based-4kscore-test-revenue-2610) — AInvest Wire, Oct 15, 2026
  OPKO Health, Inc. (NASDAQ: OPK) has announced a strategic transaction involving its diagnostics segment, valued at $722 million in cash plus an additional $150 million in potential earnout payments tied to the performance of the 4Kscore test. The deal marks a significant step in the company’s…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).